Takhzyro and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Takhzyro (lanadelumab-flyo), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Dupixent, and have Hereditary angioedema.

The phase IV clinical study analyzes which people have Swelling when taking Takhzyro. It is created by eHealthMe based on reports of 2,828 people who have side effects when taking Takhzyro from the FDA, and is updated regularly.

What is Takhzyro?

Takhzyro has active ingredients of lanadelumab-flyo. eHealthMe is studying from 2,828 Takhzyro users. Check the latest studies of Takhzyro.

What is Swelling?

Swelling is found to be associated with 2,295 drugs and 2,895 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 31, 2026

2,828 people reported to have side effects when taking Takhzyro.
Among them, 52 people (1.84%) have Swelling.

Among these 52 people:

How long have people been on Takhzyro when they have Swelling? *

What is the gender of people who have Swelling when taking Takhzyro? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Swelling when taking Takhzyro? *

What are other drugs people take besides Takhzyro? *

What are other side effects people have besides Swelling? *

Hereditary Angioedema (recurrent episodes of severe swelling): 23 people, 44.23%
Swelling Face: 18 people, 34.62%
Peripheral Swelling: 15 people, 28.85%
Abdominal Distension: 15 people, 28.85%
Swollen Tongue (swelling of tongue): 10 people, 19.23%
Eye Swelling: 8 people, 15.38%
Weight Increased: 7 people, 13.46%
Headache (pain in head): 6 people, 11.54%
Fatigue (feeling of tiredness): 6 people, 11.54%
Diarrhea: 6 people, 11.54%

What are the existing conditions these people have? *

Hereditary Angioedema (recurrent episodes of severe swelling): 14 people, 26.92%
Immune System Disorder: 9 people, 17.31%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 8 people, 15.38%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 8 people, 15.38%
Asthma: 7 people, 13.46%
Dyshidrotic Eczema (skin condition in which blisters develop on the soles of your feet and/or the palms of hands): 3 people, 5.77%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 5.77%
Angioedema (rapid swelling of the dermis): 3 people, 5.77%
Nasal Polyps (masses that develop in the lining of the nose): 3 people, 5.77%
Birth Control: 2 people, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Takhzyro and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Takhzyro:

Takhzyro (2,828 reports)

Swelling treatments and more:

Swelling (115,742 reports)

Browse all side effects of Takhzyro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,295 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lanadelumab-flyo (the active ingredients of Takhzyro) and Takhzyro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.